{
    "2018-04-19": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Mylan NV Could Be Closer to a Breakout Than Most Traders Realize",
                "features": {
                    "keywords": [
                        "Mylan",
                        "breakout",
                        "traders"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-20",
                "original_text": "Gilead Sciences Expects Decline in Earnings in Fiscal 2018",
                "features": {
                    "keywords": [
                        "Gilead",
                        "decline",
                        "earnings"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Moody's: Stable outlook for global pharmaceuticals, M&A event risk is rising",
                "features": {
                    "keywords": [
                        "Moody's",
                        "stable",
                        "outlook",
                        "global",
                        "pharmaceuticals",
                        "M&A",
                        "event",
                        "risk"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-05",
                "original_text": "Roche Hemophilia Drug Gets Breakthrough Therapy Designation",
                "features": {
                    "keywords": [
                        "Roche",
                        "hemophilia",
                        "drug",
                        "breakthrough",
                        "therapy",
                        "designation"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}